Agile Therapeutics Inc. Stock
Price
Target price
-
-
-
-
-
?11.19
WKN: A3D7A3 / Symbol: AGRX / Name: Agile Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agile Therapeutics Inc. Stock
With 2 Buy predictions and 2 Sell predictions the community is currently undecided on Agile Therapeutics Inc..
Based on the current price of 0.21 € the target price of 11 € shows a potential of 5198.65% for Agile Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Agile Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of Agile Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agile Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 0.340% | -0.416% | 17.913% | 119.146% | 24.360% | 27.221% | - |
| Evolus Inc | 5.130% | 4.237% | 16.038% | 36.667% | 35.912% | 72.028% | - |
| Salarius Pharmaceuticals Inc. | 7.850% | -5.069% | -1.905% | -64.174% | -25.766% | -98.542% | -99.992% |
Comments
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Show more
Ratings data for AGRX provided by MarketBeat
